Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial

被引：0
|
作者：
Wojciech Janczyk
Piotr Socha
Dariusz Lebensztejn
Aldona Wierzbicka
Artur Mazur
Joanna Neuhoff-Murawska
Pawel Matusik
机构：
[1] Children’s Memorial Health Institute,Department Gastroenterology, Hepatology and Eating Disorders
[2] Medical University of Bialystok,Department of Pediatrics, Gastroenterology and Allergology
[3] Children's Memorial Health Institute,Laboratory Diagnostics
[4] University of Rzeszow,Medical Faculty
[5] Medical University of Silesia,Departament Pediatric Endocrinology and Diabetes
来源：
BMC Pediatrics | / 13卷
关键词：
Non-alcoholic fatty liver disease; Omega-3 fatty acids; Polyunsaturated fatty acids; Randomized controlled trial; Children;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
    Janczyk, Wojciech
    Socha, Piotr
    Lebensztejn, Dariusz
    Wierzbicka, Aldona
    Mazur, Artur
    Neuhoff-Murawska, Joanna
    Matusik, Pawel
    [J]. BMC PEDIATRICS, 2013, 13
  • [2] Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
    Matteo Nicola Dario Di Minno
    Anna Russolillo
    Roberta Lupoli
    Pasquale Ambrosino
    Alessandro Di Minno
    Giovanni Tarantino
    [J]. World Journal of Gastroenterology, 2012, (41) : 5839 - 5847
  • [3] Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
    Di Minno, Matteo Nicola Dario
    Russolillo, Anna
    Lupoli, Roberta
    Ambrosino, Pasquale
    Di Minno, Alessandro
    Tarantino, Giovanni
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (41) : 5839 - 5847
  • [4] The significance of omega-3 fatty acids in the treatment of non-alcoholic fatty liver disease
    Anna, Mako Rebeka
    Anna, Egresi
    Anna, Blazovics
    Reka, Oszlanyi
    Krisztina, Hagymasi
    [J]. ORVOSI HETILAP, 2023, 164 (33) : 1294 - 1299
  • [5] Omega-3 polyunsaturated fatty acids: A pilot trial in non-alcoholic fatty liver disease
    Spadaro, L.
    Magliocco, O.
    Spampinato, D.
    Piro, S.
    Oliveri, C.
    Alagona, C.
    Papa, G.
    Rabuazzo, A. M.
    Purrello, F.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S264 - S264
  • [6] A CLINICAL TRIAL INVESTIGATING THE EFFECT OF OMEGA-3 FATTY ACIDS ON NON-ALCOHOLIC FATTY LIVER DISEASE
    Masterton, G.
    Shams, A.
    Walsh, J.
    Tuck, S.
    Plevris, J.
    Hayes, P.
    [J]. GUT, 2015, 64 : A256 - A256
  • [7] Role of nitric oxide in the treatment of non-alcoholic fatty liver by omega-3 fatty acids
    Beyazit, Y.
    Purnak, T.
    Kekilli, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (02) : 303 - 304
  • [8] Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
    He, Xi-Xi
    Wu, Xiao-Li
    Chen, Ren-Pin
    Chen, Chao
    Liu, Xiao-Gang
    Wu, Bin-Jiao
    Huang, Zhi-Ming
    [J]. PLOS ONE, 2016, 11 (10):
  • [9] Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials
    Chen, Lian-hui
    Wang, Yong-fen
    Xu, Qing-hong
    Chen, Shan-Shan
    [J]. CLINICAL NUTRITION, 2018, 37 (02) : 516 - 521
  • [10] Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease
    Scorletti, E.
    Bhatia, L.
    McCormick, K. G.
    Clough, G. F.
    Nash, K.
    Calder, P. C.
    Byrne, C. D.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2014, 37 (02) : 301 - 311
12345